BJBhupesh Jain

Bhupesh Jain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bhupesh Jain has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Levetiracetam vs. phenobarbitone in neonatal seizures - a randomised controlled trial at a tertiary care hospital in Southern Rajasthan

    by Dipu Das, Bhupesh Jain, Nehal Athreyi R., Hrishikesh K. G., Archana Meena

    Background: Neonatal seizures, most commonly due to hypoxic-ischemic encephalopathy (HIE), represent a medical emergency with substantial morbidity. While phenobarbitone (PB) remains the first-line antiepileptic, its efficacy varies and adverse effects are frequent. Levetiracetam (LEV) may offer a safer and equally effective alternative. Methods: In this randomized controlled trial conducted at RNT Medical College NICU, Udaipur, 120 EEG-confirmed neonatal seizure cases were randomized equally to receive either LEV or PB. Seizure control within 24 hours without switching was the primary outcome; secondary outcomes included drug switching, adverse events, discharge rate and mortality. Results: Baseline characteristics were well-matched between groups. Initial seizure control was achieved in 81.6% of the LEV group and 71.6% of the PB group (p=0.195). After switching, seizure control rates significantly favored LEV over PB (96.7% vs 86.7%, p=0.048). Adverse events occurred in 11.7% of neonates receiving LEV versus 23.3% with PB (p=0.036). No significant difference was observed in mortality or discharge rates between the two groups. Conclusions: Levetiracetam demonstrated a comparable efficacy to phenobarbitone in neonatal seizure control, with a significantly better safety profile and higher effectiveness after drug switching. LEV shows promise as a preferable first-line or adjunctive therapy for neonatal seizures.

  • Open Access

    Hearing screening in neonates admitted in neonatal intensive care unit at tertiary care centre of Southern Rajasthan

    by Santosh Roat, Bhupesh Jain, Ravikant Sankhala, Dipu Das

    Background: Hearing impairment is a common congenital condition, significantly impacting speech and social development in children. Early detection and intervention are crucial for improving outcomes, yet many cases go undiagnosed. This study aims to identify hearing impairment among neonates in a tertiary care centre using otoacoustic emission (OAE) and auditory brainstem evoked response (ABER) screening methods. Methods: A prospective observational study was conducted in the paediatric department of RNT medical college, Udaipur, over six months. Newborns admitted to the neonatal intensive care unit were screened based on risk factors as per the joint committee on infant hearing guidelines. Inclusion criteria included high-risk factors such as low birth weight, mechanical ventilation (>5 days), APGAR score etc. Descriptive analysis was performed, with statistical significance assessed using the Chi-square test. Results: Of the 750 newborns screened, 64.67% passed bilaterally in first OAE screening, remaining were referred. Among referred babies, second OAE screening showed a referral rate of 16.9%. Significant associations were found between hearing impairment and risk factors such as low birth weight, low APGAR scores, and prolonged mechanical ventilation. ABER testing confirmed hearing impairment in 9 /140 tested infants, resulting in an incidence of 55.11 per 1,000 in high-risk infants and 3.2 per 1,000 in low-risk infants. The overall incidence was 12 per 1,000 infants. Conclusions: In high-risk group hearing impairment primarily associated with low birth weight and prolonged mechanical ventilation (>5 days), low Apgar score, ototoxic drug. In high-risk group hearing impairment (5.5%) was more than low risk group (0.32%).


  • Open Access

    A study on acute undifferentiated febrile illness in children (Age 2 Months to 18 Years)

    by Bhupesh Jain, Chirag Mittal, Suresh Goyal

    A study on acute undifferentiated febrile illness in children (Age 2 Months to 18 Years) - IJMPO- Print ISSN No: - 2581-4699 Online ISSN No:- 2581-4702 Article DOI No:- 10.18231/j.ijmpo.2023.003, IP International Journal of Medical Paediatrics and Oncology-IP Int J Med Paediatr Oncol


  • Open Access

    Clinical & etiological profile of new onset unprovoked seizure in children aged 2 months to 18 years

    by Bhupesh Jain, Ravikant Sankhala

    Seizure is defined as abnormal paroxysmal neuronal discharge, which is clinically manifested by motor, sensory, autonomic or behavioral disturbances. Seizures are common in pediatrics age group and occur in 10% of children. Less than 1/3of seizures in children are caused by epilepsy. The objective of the study was to determine the clinical and etiological profile of new onset unprovoked seizure in children aged between 2 month to 18 years. A hospital based prospective single centre study at RNT Medical College, Udaipur. 111 patients admitted in Balchikitsalya with new onset unprovoked seizures during one year. Out of 111 patients with new onset unprovoked seizures, majority of patients were between 1-5 years of age with male predominance. In which most common diagnosis was seizure disorder in 78 pts (70.2%) [Generalised 76 pts (97.4%) > Focal 2 pts (2.6%)] followed by 13.5% hypocalcemic seizure, 8.1% hypoglycemic seizure. Other diagnosis was tuberous sclerosis (2.7%), white matter changes (1.8%), adrenoleukodystrophy (0.9%), arachnoid cyst (0.9%), tuberculoma (0.9%) and HIE changes (0.9%). EEG abnormality was seen in 46% of patients. Hyponatremia (36%) was significantly associated with abnormal EEG changes. MRI was done in 38.7% of the patients, out of which, abnormality was seen in only 8.6% of the children. Seizure is mainly diagnosed clinically and EEG can be normal in many patients. First episode of unprovoked seizure was common in age group of 1-5 years. EEG and Neuroimaging is useful for better diagnosis, treatment can be started on clinical diagnosis.

  • Epidemiology and Genotype Distribution of Rotavirus Gastroenteritis in Under-Five Children of South Rajasthan, India

    by Bhupesh Jain, Suresh Goyal, Lakhan Poswal, Rekha Dangi, Nayana P. Nair, Varunkumar Thiyagarajan

    Objective To determine the epidemiology of rotavirus diarrhea and its genotypes distribution among under five children from Udaipur, Rajasthan. Methods Hospital-based prospective study among children aged 0–59 mo of age hospitalized due to acute gastroenteritis and assess the clinical and epidemiological profile. Stool samples collected during 2017–2019 from 734 children, were tested by enzyme immune assay (EIA) to identify rotavirus and the samples that were positive were subjected to genotyping using published methods. Results Rotavirus was detected in 12.94% (95/734) of the stool samples. Maximum positivity (38.9%) was seen in children aged 12–23 mo followed by 34.7% in 6–11 mo of age. Detection rates were higher (46.31%, 44/95) during winter months of December–February; 65% children with rotavirus diarrhea had severe dehydration followed by moderate dehydration in 32% of cases. G3P[8] (40, 43.01%) was the commonest genotype followed by G9P[4] (10, 10.75%). Conclusion Among under-five children hospitalized due to acute gastroenteritis in a tertiary care setting in Udaipur, Rajasthan, 12.9% of children were rotavirus positive with predominant (43.01%) circulation of G3P[8] strains.